Pregnancy is associated with increased iron requirements due to fetal growth, placental development, and expansion of maternal blood volume. Insufficient iron intake or impaired absorption frequently leads to iron deficiency anemia, particularly in developing countries and populations with inadequate nutrition. Untreated anemia during pregnancy contributes to maternal fatigue, impaired immunity, postpartum hemorrhage, and poor neonatal outcomes. Despite advances in obstetric care, iron deficiency anemia continues to affect a large proportion of pregnant women worldwide. Early laboratory diagnosis and preventive interventions play a crucial role in minimizing maternal and fetal complications and improving pregnancy outcomes.
The aim of the study was to assess the effectiveness of early diagnostic methods and preventive measures for iron deficiency anemia in pregnant women and to evaluate their impact on maternal and fetal outcomes.
The study included 100 pregnant women aged 20–38 years who attended antenatal clinics during the first and second trimesters of pregnancy. Clinical examination and laboratory investigations were performed, including complete blood count, hemoglobin level, serum ferritin, serum iron, and transferrin saturation assessment. Patients were divided into two groups: a prevention group receiving early iron supplementation and nutritional counseling, and a control group receiving standard prenatal care. Maternal health status, pregnancy progression, and fetal outcomes were monitored throughout gestation. Statistical analysis was performed to compare anemia prevalence and pregnancy outcomes between groups.
The study revealed that iron deficiency anemia was more frequently detected during the second trimester among women who had not received early preventive measures. Pregnant women in the prevention group demonstrated significantly higher hemoglobin and ferritin levels compared to the control group (p<0.05). Early iron supplementation reduced the incidence of moderate and severe anemia and was associated with lower rates of fatigue, dizziness, and obstetric complications. Neonatal outcomes, including birth weight and gestational age at delivery, were significantly better among women receiving preventive treatment. Regular laboratory monitoring enabled early identification of latent iron deficiency before the development of clinically significant anemia.
Early diagnosis and prevention of iron deficiency anemia are essential components of comprehensive prenatal care. Routine screening using hematological and biochemical markers allows timely identification of iron deficiency in pregnant women. Preventive iron supplementation, balanced nutrition, and continuous monitoring significantly reduce maternal and fetal complications associated with anemia. Implementation of effective preventive programs may improve maternal health outcomes and contribute to healthier pregnancies and neonatal development.
1. World Health Organization. Iron deficiency anaemia: assessment, prevention and control. WHO Press; 2001.
2. Milman N. Iron deficiency and anemia in pregnant women in developed countries. Ann Hematol. 2011;90(11):1247–1253.
3. Pavord S., et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156(5):588–600.
4. Peña-Rosas J.P., et al. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(7):CD004736.
5. Bothwell T.H. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr. 2000;72(1):257S–264S.
6. Breymann C. Iron deficiency anemia in pregnancy. Semin Hematol. 2015;52(4):339–347.
7. Means R.T. Iron deficiency and iron deficiency anemia during pregnancy. Clin Obstet Gynecol. 2019;62(1):3–13.
8. Auerbach M., Adamson J.W. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31–38.
9. med1.uz — educational resources on pregnancy and iron deficiency anemia.
10. Allen L.H. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr. 2000;71(5):1280S–1284S.